Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,290 papers from all fields of science
Search
Sign In
Create Free Account
pentamethylmelamine monohydrochloride
Known as:
1,3,5-Triazine-2,4,6-triamine, N,N,N',N', N''-pentamethyl-, monohydrochloride (9CI)
, Melamine, N2,N2,N4,N4,N6-pentamethyl-, monohydrochloride
, Pentamethylmelamine monoHCl
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pentamethylmelamine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Role of Nociceptin/Orphanin FQ and NOP Receptors in the Response to Acute and Repeated Restraint Stress in Rats
G. Delaney
,
K. Dawe
,
+5 authors
A. Fulford
Journal of neuroendocrinology
2012
Corpus ID: 17081680
Central nociceptin/orphanin FQ (N/OFQ)‐expressing neurones are abundantly expressed in the hypothalamus and limbic system and are…
Expand
2012
2012
In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
K. Nakao
,
Y. Togashi
,
+6 authors
H. Mochizuki
European Journal of Pharmacology
2012
Corpus ID: 23407823
2009
2009
Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
Alison M. Ray
,
R. Kelsell
,
+4 authors
A. Calver
European Journal of Pharmacology
2009
Corpus ID: 13111190
2004
2004
On the Mössbauer spectra of isopenicillin N synthase and a model (FeNO)7 (S = 3/2) system.
Yong Zhang
,
E. Oldfield
Journal of the American Chemical Society
2004
Corpus ID: 5957672
We have carried out a series of density functional theory (DFT) calculations to predict the 57Fe Mössbauer quadrupole splittings…
Expand
2003
2003
Synthesis of N,N',N"-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor.
Hyeung‐geun Park
,
Mi-kyung Park
,
+14 authors
S. Jew
Bioorganic & Medicinal Chemistry Letters
2003
Corpus ID: 2648416
2001
2001
Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
M. Rashid
,
M. Watanabe
,
M. Nakazawa
,
T. Nakamura
,
K. Hattori
,
T. Nagatom
Japanese Journal of Pharmacology
2001
Corpus ID: 25555279
This study investigated the binding affinities of a newly synthesized 5-HT2 antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d…
Expand
2000
2000
Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-for myl-4-piperidinecarboxamide monohydrochloride…
H. Gong
,
M. Rashid
,
+5 authors
T. Nagatomo
Biological and Pharmaceutical Bulletin
2000
Corpus ID: 24223489
Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene…
Expand
1999
1999
A search for new metabolites of N,N',N''-triethylenethiophosphoramide.
M. J. van Maanen
,
I. M. Tijhof
,
+5 authors
J. Beijnen
Cancer Research
1999
Corpus ID: 25844836
An attempt was made to unravel the metabolic profile of the alkylating agent N,N',N''-triethylenethiophosphoramide (thioTEPA…
Expand
1998
1998
Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatography.
R. J. Van Maanen
,
R. D. van Ooijen
,
J. W. Zwikker
,
A. Huitema
,
S. Rodenhuis
,
J. Beijnen
Journal of Chromatography B: Biomedical Sciences…
1998
Corpus ID: 27456875
1986
1986
Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
P. Gutiérrez
,
S. Biswal
,
R. Nardino
,
N. Biswal
Cancer Research
1986
Corpus ID: 10081744
To analyze the mode of action of diaziquone [AZQ] on DNA, we examined the activity of two AZQ analogues and N,N',N…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE